Updates on Respiratory Dialysis – September 2014
The latest news and developments related to extracorporeal CO2 removal and the Hemolung RAS.
Opportunities for ECCO2R Education
ESICM Pre-Course: Fundamentals of Extracorporeal CO2 Removal
Sunday 28 September 2014
1:30 PM to 4:00 PM
Hotel Barceló Atenea Mar, Barcelona
Join us for this special pre-ESICM educational event in Barcelona! “Fundamentals of Extracorporeal CO2 Removal (ECCO2R)” will address practical questions about ECCO2R therapy. What is the scientific rationale for ECCO2R? In what types of patients and at what disease stage should it be applied? What technologies are available? How is ECCO2R different from ECMO? How do you start an ECCO2R program?
Hemolung RAS User Group Meeting
Tuesday, September 30th from 12:00-14:00
We invite you to join us on Tuesday, September 30th from 12:00-14:00 at the ESICM for a Hemolung User Group Meeting. Just like our successful meeting at EURO-ELSO, we have planned an engaging roundtable discussion, with an emphasis on case examples, practical tips, and sharing your feedback and ideas for improving the Hemolung RAS. Lunch will be served. RSVP requested by September 23rd! Case presentations are welcomed and encouraged!
RSVP via email to: email@example.com by September 23rd
Webinar Series: Respiratory Dialysis – From Physiology to Practice
Mark your calendar and register now for this special online learning event! In part one of this program, Dr. Vito Fanelli of the University of Turin will present the physiology of CO2 clearance in critical care followed by a discussion of indications for extracorporeal CO2 removal. Future webinars will cover the practical aspects of implementing Respiratory Dialysis in exacerbated COPD and ARDS.
Date: Thursday, September 25, 2014
Time: 3:00 PM – 3:45 PM CEST
Register online at: www.alung.com/2014webinar
The NEW Hemolung Registry
Simplified data collection will allow for a focus on Hemolung performance and clinical outcomes
We are pleased to announce the launch of our completely new Hemolung Registry Program! Based on your feedback, we have completely revamped this program to simplify data collection and focus on key measures of clinical performance. We estimate that the new registry form will take less than 15 minutes to complete. The new form is a writable PDF which allows you to type data into the form, save it, and email it to ALung. Handwritten forms may continue to be submitted as well.
All users of the Hemolung RAS are encouraged to participate in this program as we work together to build a body of evidence for the use of extracorporeal CO2 removal. We will also begin to make data reports available to program participants going forward.
The NEW Hemolung Registry form is available online at: www.alung.com/registry
Clinical Trial Updates
Hemolung ARDS Pilot Study
A new investigator-initiated study of the Hemolung RAS in patients with moderate ARDS is now underway. Under the leadership of co-PIs Professors
Marco Ranieri and Alain Combes, the Hemolung RAS is being evaluated as a tool to facilitate ultraprotective ventilation (VT = 4 mL/kg) in patients with moderate ARDS. Enrollment in this study is ongoing and expected to conclude by the end of this year.
Pilot RCT of Hemolung RAS in AE-COPD
Dr. Nicholas Barrett of Guy’s and St Thomas’ NHS Foundation Trust will soon begin recruiting patients for his investigator-initiated study titled “Extracorporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD.” The aim of this 24-patient randomized pilot study is to assess the ability of the Hemolung RAS to shorten the duration of NIV and reduce the likelihood of intubation.
For more information on this study, please visit: clinicaltrials.gov/ct2/show/NCT02086084
Product Development Update
You asked for it, and it’s coming soon – a fully pre-connected Hemolung Cartridge Kit! With this new kit, the only connections you will need to make are to the catheter. This update will make setup and priming of the circuit faster and easier. We are also introducing new packaging for the Hemolung Catheter which puts all components in one sterile tray, making handling of the insertion accessories much easier. We are in the final steps of our regulatory approvals for these new kits and anticipate shipping them by year end.